We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Glycemic Response Testing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01536860
Recruitment Status : Completed
First Posted : February 22, 2012
Results First Posted : November 27, 2013
Last Update Posted : November 27, 2013
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc.

February 16, 2012
February 22, 2012
September 11, 2012
November 27, 2013
November 27, 2013
February 2012
March 2012   (Final data collection date for primary outcome measure)
Glycemic Response Measured as the Positive Incremental Area Under the Time-concentration Curve(iAUC) Calculated From Individual Glucose Measurements Upon Consumption of Control and Experimental Test Food Products [ Time Frame: 0-120 minutes ]
The individual glucose measurements were collected at baseline (prior to consumption of each test food product and 15, 30, 45, 60, 90 and 120 minutes following the initiation of consumption of each test food product. The positive incremental area under the time-concentration curve (iAUC) was then calculated for the entire 120 minutes after consumption of each test food product. The results show the differential treatment-related effect on the time-concentration curve (iAUC) for the entire 120 minutes post consumption of each test food product.
Glycemic response upon consumption of control and experimental test food products [ Time Frame: 0-120 minutes ]
Complete list of historical versions of study NCT01536860 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Glycemic Response Testing
Glycaemic Response Testing
The purpose of this study is to assess whether added food ingredient(s) affect glycemic responses to a liquid meal tolerance test (LMTT).
Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Basic Science
  • Glycemic Index
  • Glycemic Response
Other: Dietary Intervention
300 ml of liquid food product
  • Placebo Comparator: Control Test Drink
    control drink
    Intervention: Other: Dietary Intervention
  • Experimental: Experimental Test Drink 1
    control drink containing ingredient 1
    Intervention: Other: Dietary Intervention
  • Experimental: Experimental Test Drink 2
    Control drink containing ingredient 2
    Intervention: Other: Dietary Intervention
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
March 2012
March 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male or female (not less than 40% males or females
  • Non-smoker
  • Aged 18 to 55 years
  • Have a body mass index between 18.5 to 29.99 kg/m2
  • Healthy, non-diabetic, no gastric bypass surgery
  • Not allergic to mustard, dairy or soy
  • Having a fasting plasma glucose (finger stick) <100 mg/dl (<5.5 mmol/L)
  • Willing and able to provide written informed consent
Sexes Eligible for Study: All
18 Years to 55 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United Kingdom
Not Provided
Not Provided
Mondelēz International, Inc.
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Principal Investigator: Valerie Hart, SCS, Dip, MICR RSSL
Mondelēz International, Inc.
November 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP